Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine
- PMID: 12220392
- DOI: 10.1046/j.1468-1331.2002.04455.x
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine
Comment on
-
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up.Eur J Neurol. 2001 Jul;8(4):361-2. doi: 10.1046/j.1468-1331.2001.00224.x. Eur J Neurol. 2001. PMID: 11422435 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
